SOUTH SAN FRANCISCO, Calif. — Pliant Therapeutics, Inc. today announced that it has raised $62 million in a Series B financing. The funds will support the initiation and proof-of-concept clinical trials in idiopathic pulmonary fibrosis (IPF) and primary sclerosing cholangitis (PSC), as well as ongoing drug discovery programs targeting other fibrotic diseases. The financing was led by Cowen Healthcare … Continue reading Pliant Therapeutics Raises $62 Million in Series B Financing